Condition
Chemotherapy Induced Peripheral Neuropathy (CIPN) clinical trials and research
As of November 12, 2026, Find a Trial lists 16 Chemotherapy Induced Peripheral Neuropathy (CIPN) clinical trials that are recruiting, at sites in 11 countries (most in China (3), United States (3), Spain (2)). By phase: Phase 2/3 (2), Phase 3 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 16Clinical trials
- 11Countries
Newest Chemotherapy Induced Peripheral Neuropathy (CIPN) clinical trials
All recruiting trials (16)
-
Cryotherapy during weekly paclitaxel to reduce chemotherapy-induced numbness and tingling
This study tests whether applying cryotherapy to hands and feet during weekly paclitaxel helps prevent CIPN in women with breast cancer.
-
Electroacupuncture and Exercise for Chemotherapy-Induced Peripheral Neuropathy
This study tests whether adding a structured exercise program to electroacupuncture helps cancer survivors with CIPN more than electroacupuncture alone.
-
Virtual exercise program to help with chemotherapy-induced nerve symptoms
This trial tests whether a remote, personalized exercise program (EX-CIPN) can reduce CIPN symptoms and related disability in cancer survivors who have persistent neuropathy after chemotherapy, compared with usual care.
-
Acupuncture and compression to prevent chemotherapy-induced nerve damage in breast cancer
This trial will test whether wearing compression garments and/or receiving acupuncture during taxane chemotherapy can prevent chemotherapy-induced peripheral neuropathy in adults with early-stage breast cancer.
-
PEA and Scutellaria combined with exercise for chemotherapy-related nerve pain
This trial will see if taking PEA and Scutellaria together with therapeutic exercise helps adults who have nerve pain after chemotherapy.
-
Assessing Functional Impairments in CIPN Patients
This study tests how CIPN affects daily function by using functional tests alongside patient self-reports to see how well the tests reflect everyday difficulties.
-
Closed-loop spinal cord stimulation for painful chemotherapy-induced peripheral neuropathy
This observational project will try closed-loop spinal cord stimulation to reduce neuropathic pain in adults who developed peripheral neuropathy after chemotherapy.
-
Lilac low-pressure glove and boot to protect nerves during chemotherapy
Tests if wearing Lilac low-pressure gloves and boots during certain oxaliplatin- or paclitaxel-based chemotherapy can lessen peripheral nerve damage in adults.
-
Great toe strength in people with chemotherapy-induced peripheral neuropathy
This research tests whether a small device called ToeScale can measure great toe strength in adults with CIPN and in matched healthy adults.
-
GM1 to prevent nerve damage from albumin-paclitaxel in breast cancer patients.
This trial will test whether GM1 can prevent peripheral nerve damage in adults with breast cancer who are receiving albumin-paclitaxel chemotherapy.
-
Cold salt-water foot baths to prevent paclitaxel-related nerve damage
This study tests whether taking cold salt-water or plain cold-water foot baths during paclitaxel chemotherapy can prevent or reduce chemotherapy-related peripheral nerve damage in women with breast cancer.
-
Personalized exercise to prevent chemotherapy-related nerve damage
This study will see if a tailored exercise program can prevent nerve-related symptoms in adults getting taxane- or platinum-based chemotherapy for breast, gynecological, or colon cancer.
-
Using electroacupuncture to help with chemotherapy-induced nerve pain
This study is testing if electroacupuncture can help reduce nerve pain from chemotherapy in patients who are struggling with symptoms like numbness and tingling.
-
Examining gut microbiome profiles in patients with chemotherapy-induced neuropathy
This study is trying to see if the gut bacteria of patients getting ozone therapy for chemotherapy-related nerve pain can help explain why some feel better while others don’t.
-
Ozone therapy for numbness and tingling from chemotherapy
This study is testing if ozone therapy can help reduce numbness and tingling in cancer patients who have nerve damage from chemotherapy.
-
Sensory testing to guide medication choice for painful peripheral neuropathy
This will try to see if sensory testing can predict which people with painful peripheral neuropathy get more pain relief from duloxetine or pregabalin than from placebo.
Related topics
Quick answers
How many Chemotherapy Induced Peripheral Neuropathy (CIPN) clinical trials are recruiting right now?
16, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 11 countries. The most sites are in China (3 trials), United States (3 trials), Spain (2 trials), Italy (2 trials), Turkey (Türkiye) (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 2, Phase 3: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.